Skip to main content

Table 2 Biochemistry Tests Dietary Intake, Anthropometric Characteristics and Blood Pressure at the Baseline and After Intervention

From: Vitamin D supplementation and serum heat shock protein 60 levels in patients with coronary heart disease: a randomized clinical trial

 

Placebo (35 patient)

Vitamin D (32 patient)

P value2

HSP 60a (ng/l)

 Baseline

599.40 (478.80, 1089.00)

603.15 (498.12, 1416.50)

0.880

 Endpoint

765.40 (566.80, 1450.00)

649.20 (453.57, 1138.25)

0.142

 P value1

0.083

0.104

 

IL17a (ng/l)

 Baseline

77.70 (69.50, 183.50)

86.55 (76.27, 122.52)

0.251

 Endpoint

82.00 (70.70, 161.20)

77.00 (69.30, 130.80)

0.585

 P value1

0.187

0.183

 

TNFα (pg/ml)

 Baseline

2.18 (01.86)

2.10 (1.62)

0.894

 Endpoint

2.79 (2.68)

3.04 (3.48)

0.734

 P value1

0.095

0.111

 

PAB (HK)

 Baseline

148.02 (69.07)

168.56 (71.39)

0.236

 Endpoint

149.89 (65.54)

166.50 (62.29)

0.293

 P value1

0.820

0.866

 

25(OH) D3 (ng/ml)

 Baseline

17.26 (6.95)

16.62 (7.46)

0.717

 Endpoint

27.54 (25.88)

63.48 (25.86)

<  0.001

 P value1

0.016

<  0.001

 

LDL (mg/dl)

 Baseline

81.48 (22.17)

89.37 (26.78)

0.192

 Endpoint

80.34 (29.41)

84.28 (29.49)

0.586

 P value1

0.722

0.162

 

HDL (mg/dl)

 Baseline

37.68 (7.42)

35.81 (7.50)

0.308

 Endpoint

35.68 (9.94)

34.96 (7.54)

0.743

 P value1

0.163

0.459

 

TC (mg/dl)

 Baseline

124.05 (29.89)

134.37 (33.05)

0.184

 Endpoint

124.77 (37.01)

128.09(38.08)

0.719

 P value1

0.858

0.153

 

TG (mg/dl)

 Baseline

136.48 (75.73)

154.50 (89.96)

0.377

 Endpoint

153.02 (80.01)

172.37 (98.19)

0.382

 P value1

0.160

0.124

 

PTH (pg/ml)

 Baseline

37.80 (15.08)

43.35 (23.31)

0.258

 Endpoint

40.72 (22.61)

23.54 (17.10)

0.248

 P value1

0.306

0.003

 

Energy (cal)

 Baseline

1733.28 (297.96)

1859.48 (327.65)

0.103

 Endpoint

1776.27 (292.26)

1889.46 (298.51)

0.122

 P value1

0.403

0.617

 

Vitamin Da (ug)

 Baseline

1.34 (0.08, 2.64)

0.94 (0.36, 2.14)

0.660

 Endpoint

1.56 (0.96, 2.61)

1.39 (0.66, 2.41)

0.514

 P value1

0.647

0.121

 

Calcium (mg)

 Baseline

720.13 (250.60)

723.90 (217.96)

0.948

 Endpoint

807.77 (243.86)

785.90 (244.23)

0.715

 P value1

0.108

0.266

 

BMI (kg/m2)

 Baseline

28.4 (3.37)

27.05 (3.68)

0.301

 Endpoint

28.31 (3.34)

27.37 (3.64)

0.276

 P value1

0.475

0.423

 

WC (cm)

 Baseline

94.17 (10.29)

92.43 (12.48)

0.536

 Endpoint

93.91 (10.38)

91.46 (12.62)

0.388

 P value1

0.324

0.005

 

Weight (kg)

 Baseline

82.12 (10.07)

79.01 (11.17)

0.233

 Endpoint

81.85 (9.69)

78.27 (70.79)

0.158

 P value1

0.319

0.103

 

Fat percentage (%)

 Baseline

32.65 (4.57)

33.97 (6.45)

0.332

 Endpoint

32.75 (4.81)

32.84 (5.79)

0.943

 P value1

0.729

0.029

Systolic blood pressure (mmHg)

 Baseline

126.51 (12.70)

129.00 (15.82)

0.479

 Endpoint

124.4 (8.29)

125.15 (14.16)

0.796

 P value1

0.146

0.009

Diastolic blood pressure (mmHg)

 Baseline

80.14 (8.7)

79.93 (10.61)

0.931

 Endpoint

78.28 (7.46)

75.93 (8.74)

0.240

 P value1

0.003

0.010

  1. a For descriptive statistics, Man-Whitney test was used for between-groups comparisons (Median (IQR)). Wilcoxon test was used for within-groups comparisons (Mean (SD)).1Within-group P values based on paired t-test, 2 Between group P values based on t-test. 3 Post-intervention between-group P value based on ANCOVA with baseline value of each variable and BMI as covariates. HSP 60, IL17, Interleukin 17; TNFα Tumor necrosis factor α, PAB Pro oxidant Anti-oxidant Balance, LDL Low density lipoprotein, HDL High Density Lipoprotein, TC Total Cholesterol, TG Triglyceride, PTH Parathyroid Hormone, BMI Body Mass Index, WC Waist Circumference